<?xml version="1.0" encoding="UTF-8"?>
<ref id="B38-cancers-12-00713">
 <label>38.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Turner</surname>
    <given-names>N.C.</given-names>
   </name>
   <name>
    <surname>Ro</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Andr√©</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Loi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Verma</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Iwata</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Harbeck</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Loibl</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Huang Bartlett</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer</article-title>
  <source>N. Engl. J. Med.</source>
  <year>2015</year>
  <volume>373</volume>
  <fpage>209</fpage>
  <lpage>219</lpage>
  <pub-id pub-id-type="doi">10.1056/NEJMoa1505270</pub-id>
  <pub-id pub-id-type="pmid">26030518</pub-id>
 </element-citation>
</ref>
